Literature DB >> 20002746

A comparative study of RNA and DNA as internal gene expression controls early in the developmental cycle of Chlamydia pneumoniae.

Patrik Engström1, Leslie Bailey, Thomas Onskog, Sven Bergström, Jörgen Johansson.   

Abstract

Many microbial pathogens invade and proliferate within host cells and the molecular mechanism underlying this behavior is currently being revealed for several bacterial species. Testing clinically relevant antibacterial compounds and elucidating their effects on gene expression requires adequate controls, especially when studying genetically intractable organisms such as Chlamydia spp., for which various gene fusions cannot be constructed. Until now, relative mRNA levels in Chlamydia have been measured using different internal gene expression controls, including 16S rRNA, mRNAs, and DNA. Here, we compared the advantages and disadvantages of various internal expression controls during the early phase of Chlamydia pneumoniae development. The relative abundance of target mRNAs varied using the different internal control RNAs. This was partly due to variation in the transcript stability of the RNA species. Also, seven out of nine of the analyzed RNAs increased fivefold or more between 2 and 14 h postinfection, while the amount of DNA and number of cells remained essentially unaltered. Our results suggest that RNA should not be used as a gene expression control during the early phase of Chlamydia development, and that intrinsic bacterial DNA is preferable for that purpose because it is stable, abundant, and its relative amount is generally correlated with bacterial numbers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002746     DOI: 10.1111/j.1574-695X.2009.00631.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  5 in total

1.  Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (HemG) and Chlamydia trachomatis infectivity.

Authors:  Patrik Engström; Bidong D Nguyen; Johan Normark; Ingela Nilsson; Robert J Bastidas; Asa Gylfe; Mikael Elofsson; Kenneth A Fields; Raphael H Valdivia; Hans Wolf-Watz; Sven Bergström
Journal:  J Bacteriol       Date:  2013-07-12       Impact factor: 3.490

2.  Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors.

Authors:  Vítor Borges; Miguel Pinheiro; Minia Antelo; Daniel A Sampaio; Luís Vieira; Rita Ferreira; Alexandra Nunes; Filipe Almeida; Luís J Mota; Maria J Borrego; João P Gomes
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

3.  Global survey of mRNA levels and decay rates of Chlamydia trachomatis trachoma and lymphogranuloma venereum biovars.

Authors:  Rita Ferreira; Vítor Borges; Maria José Borrego; João Paulo Gomes
Journal:  Heliyon       Date:  2017-07-26

4.  Characterization of Chlamydia muridarum TC0668 Protein: Localization, Expression, and Inflammation-Inducing Effects on Host Cell.

Authors:  Na Liu; Xiaofang Li; Hao Chen; Chuan Wang; Wenjing Xiang; Shui Tan; Chenchen Song; Emmanuel Wirekoh Arthur; Asamoah Maxwell; Derrick Annang; Zhou Zhou
Journal:  Curr Microbiol       Date:  2022-09-20       Impact factor: 2.343

5.  Quantifying promoter activity during the developmental cycle of Chlamydia trachomatis.

Authors:  Yanguang Cong; Leiqiong Gao; Yan Zhang; Yuqi Xian; Ziyu Hua; Hiba Elaasar; Li Shen
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.